February 5, 2026 – Your Invest Master

Investing

TomaGold Borehole EM Survey Confirms Berrigan Deep Zone

February 5, 2026 Investing 8 Mins Read

Survey also validates significant mineralization and unlocks new targets

Highlights

Direct correlation with mineralization : The modeled geophysical plates explain the presence of semi-massive to massive sulfides intersected in holes TOM-25-009 to TOM-25-015.
Priority target BER-14C : Identification of a major 160 x 300 m plate, open at depth and to the northeast , suggesting the presence of a significant massive sulfide lens near drill hole TOM-25-014.
Confirmation of Berrigan Deep : The TOM-25-015 drill hole perfectly intersects the southeast extension of the BER-14C plate, validating the continuity of the mineralized system at a depth of over 450 metres .

TomaGold Corporation (TSXV: LOT,OTC:TOGOF; OTCPK: TOGOF) (‘ TomaGold ‘ or the ‘ Company ‘) is pleased to announce the interpretation results of the borehole electromagnetic (BHEM) survey completed on its Berrigan Mine project, located in the Chibougamau mining camp.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205830419/en/

Figure 1: TomaGold’s borehole EM survey confirms Berrigan Deep Zone

The survey, conducted by Abitibi Geophysics, modeled ten conductive plates of varying orientation and size that not only corroborate the high-grade intersections already announced, but also indicate significant extension potential, particularly with the discovery of the Berrigan Deep zone.

David Grondin, President and CEO of TomaGold, stated: ‘The geophysics confirm what our drill cores indicated: Berrigan Mine sits on a large-scale mineralized system. The BER-14C plate, in particular, extends the mineralization signature of holes TOM-25-014 and TOM-25-015 with a vector pointing to an even more conductive zone to the northeast.’

Technical analysis of the plates

The survey uses Terrascope PRO5U transmitters (up to 15 kW) powered by a Wildcat generator to transmit a bipolar signal in a 530 x 560 m surface loop with a current of 30 A. The borehole measurements are taken at frequencies of 5 Hz and 1 Hz using a GPS-synchronized DigiAtlantis triaxial probe, which captures the components of the magnetic field. Finally, the data is processed and modeled using specialized Maxwell and Oasis Montaj software, with the conductive plates shown in green in Figure 1.

Table 1: Comparative analyses Drilling/BHEM

Sector / Drill hole	Intersection (base interval)	Geophysical plate	Conductance (S)	Plate dimensions (m)
Berrigan Deep (TOM-25-015)	1.98% Zn, 0.82 Au g/t and 3.21 Ag g/t over 98.50 m	BER-14C	5000	160×300
West Extension (TOM-25-014)	4.55% Zn, 4.94 Au g/t and 56.44 Ag g/t over 2.10 m	TOM-25-014_B	5000	85×90
Main Zone (TOM-25-009)	1.40% Zn, 1.12 Au g/t and 7.55 Ag g/t over 48.05 m	TOM-25-009_C	4000	40×40
North Zone (TOM-25-012/13)	Results pending	TOM-25-12+13_A	1900	70×220

Source: Rapport technique d’Abitibi Géophysique (25QC084-BT TomaGold, Berrigan, BHEM, 2026)

Note: TomaGold has reverted to reporting elemental assay results rather than metal equivalent grades. The mineralization style encountered at Berrigan Mine differs from typical sulphide deposits in the surrounding area, including Scott Lake, Lemoine and Mattagami, as well as outside the immediate region such as Normétal, Rouyn-Noranda and Timmins. As a result, metallurgical recovery assumptions remain uncertain at this stage and cannot currently support the use of metal equivalent calculations.

Next Steps

TomaGold plans to:

Drill three new holes (TOM-26-016 to TOM-26-018) to test the northeast and depth extensions of the BER-14C conductive plate.
Conduct additional follow-up drilling to extend holes TOM-25-010, 011, and 013 with the goal of reaching modeled targets, and drill a corner hole from hole TOM-25-015.
Conduct a low-frequency surface electromagnetic (EM) survey to better define the thickness, continuity, and lateral extent of the mineralized system.

About the Berrigan Mine Project
The Berrigan Mine property consists of 16 claims totalling 483 hectares located 4 km north-northwest of the town of Chibougamau. TomaGold has an option to acquire 100% of the property from Chibougamau Independent Mines Inc.

The property has been the subject of more than one historical estimate. Met-Chem Canada Inc. prepared the most recent of these in April 2001 in a report titled: ‘Pre-feasibility study: Etude Conceptuelle, Projects Berrigan and Tortigny’ by Chuinard et al. In the report, a resource estimate completed using polygonal estimation techniques stated 1.39 Mt grading 3.17% Zn and 1.77 g/t Au on the main Berrigan Mine zone. No resource classifications were given for the resource (GM61359).

The mineral resource estimate presented above is historical in nature and was not prepared in accordance with National Instrument 43-101 standards. Accordingly, the reader is cautioned not to rely on this estimate, as the Company is not treating the estimate as a current mineral resource. The qualified person has not done sufficient work to make the resource current. Substantial data compilation, verification, and, potentially, additional drilling and resampling would be required by a qualified person before the historical estimate could be classified as a current mineral resource. There can be no assurance that any portion of the historical mineral resource will ultimately be confirmed or demonstrated to be economically viable. For further information regarding the Berrigan Mine Project, please consult the press release dated September 13, 2023 .

Technical Disclosure
The drilling program was managed by Explo-Logik of Val-d’Or, Québec. Drill core was split in half, with one half submitted to AGAT Laboratories at Val-d’Or for analysis. Gold was analyzed by fire assay (50 g) with atomic absorption finish, while base metals were analyzed by four-acid digestion with ICP-OES finish. Samples with gold grades greater than 10 g/t are reprocessed using metallic screening with a 106 µm cutoff. The processed material is split and analyzed by fire assay with ICP-OES finish to extinction. A separate split is prepared to independently analyze mineralized intervals with a target grade greater than 1.00% Cu-Zn using a Na₂O₂ fusion with ICP-OES or ICP-MS finish. Sample preparation duplicates, certified reference standards, and blanks are inserted into the sample stream.

The technical content of this press release has been reviewed and approved by Jean Lafleur, P.Geo., Vice President of Exploration of the Company, and Suzie Tremblay, P.Geo., Vice President of Operations at Explo-Logik Inc. and a consultant to TomaGold, each acting as a Qualified Person under National Instrument 43-101.

About TomaGold
TomaGold Corp. (TSXV: LOT,OTC:TOGOF, OTCPK: TOGOF) is a Canadian junior mining company focused on the acquisition, exploration, and development of high-potential precious and base metal projects, with a primary focus on gold and copper in Québec and Ontario. The Company’s core assets are located in the Chibougamau Mining Camp in northern Québec, where it owns the Obalski gold-copper-silver project and holds options to acquire 12 additional properties, including the Berrigan Mine, Radar, David, and Dufault projects. TomaGold also holds a 24.5% joint venture interest in the Baird gold property near the Red Lake Mining Camp in Ontario. In addition, the Company has lithium and rare earth element (REE) projects in the James Bay region, strategically positioned near significant recent discoveries.

Follow TomaGold:

WhatsApp: https://www.whatsapp.com/channel/0029Vb79qG6LdQeiiErI1e27
LinkedIn: https://www.linkedin.com/company/tomagold-corporation
Facebook: https://www.facebook.com/TomaGoldCorporation
Instagram: https://www.instagram.com/tomagoldcorp
X: https://x.com/tomagoldcorp

Cautionary Statement on Forward-Looking Information
This news release includes certain statements that may be deemed ‘forward-looking statements’. All statements in this news release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words ‘expects’, ‘plans’, ‘anticipates’, ‘believes’, ‘intends’, ‘estimates’, ‘projects’, ‘potential’ and similar expressions, or that events or conditions ‘will’, ‘would’, ‘may’, ‘could’ or ‘should’ occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include the potential results of exploration and drilling activities, market prices, continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company’s management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management’s beliefs, estimates, opinions, or other factors should change.

Neither TSX Venture Exchange nor its Regulations Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260205830419/en/

David Grondin
President and Chief Executive Officer
(514) 583-3490
www.tomagoldcorp.com

News Provided by Business Wire via QuoteMedia

This post appeared first on investingnews.com

Keep Reading

Politics

Pro-life group finds Biden-era FDA policy is driving 500 abortions per day, says Trump has power to end it

February 5, 2026 Politics 6 Mins Read

A pro-life group is releasing a new report claiming abortions have continued to rise nationwide since 2020 because of a Biden administration FDA policy that allows abortion pills to be prescribed via telehealth and shipped by mail — a move the group says the Trump administration could reverse.

In a report obtained by Fox News Digital, the Restoration of America Foundation (ROAF) argues that a COVID-era FDA policy under former President Joe Biden is driving an estimated more than 500 mail-order chemical abortions per day, citing data from Guttmacher and WeCount.

The data also shows that chemical abortions now account for the majority of abortions, making up about 63% in 2023, a jump from 39% in 2017.

The report also estimates that there were roughly 170,000 additional abortions in 2024 than would have happened if the abortion rate had remained at 2019 levels.

‘Since hitting a low in 2017, the national abortion rate has seen a persistent and troubling climb,’ the report states. ‘In 2019, the last full year that abortion by mail was clearly illegal, there were an estimated 916,460 abortions. Using our estimate for 2024, the overall growth in abortion from 2019 to 2024 was 22 percent. Over the same window, the U.S. population grew by just 2.9 percent. Had the abortion rate remained steady from 2019, there would have been 171,103 fewer abortions in 2024.’

The findings show abortion-by-mail made up roughly one in four abortions in the U.S. in the first half of 2025.

WeCount data cited in the report also shows an estimated 244,590 do-it-yourself abortions were facilitated by telehealth in 2024, including more than 120,000 pills sent into states where abortion was restricted or banned after the Supreme Court overturned Roe V. Wade in 2022, giving the power to make abortion laws back to the states.

The Biden administration policy removed safety standards that required women to see a doctor to be prescribed mifepristone, allowing it to be prescribed through telehealth and sent by mail. The report argues that the FDA under Biden justified the change using limited studies and adverse-event data, despite most mandatory reporting requirements for mifepristone complications being removed in 2016 under the Obama administration. A research paper in 2021 additionally compared adverse-event data with Planned Parenthood data and concluded that the system is ‘inadequate’ to evaluate the safety of mifepristone abortions.

‘People are calling up and saying whatever they need to say to get the drug in the mail,’ ROAF CEO Doug Truax said in an interview with Fox News Digital. ‘The point that we’re making is that abortions are on the rise dramatically. 874,000 in 2023, up to 1.1 million in 2024. Then on this trajectory, by the time President Trump leaves office, it’d be about 1.4 million a year. And so it’s largely driven by the drugs going out in the mail.’

‘There’s about 150 women a day that are being seriously harmed by this drug,’ Truax continued. ‘So we need to get them to go see the doctor. The doctor needs to verify where they’re at with the pregnancy. Obviously, if it’s an ectopic pregnancy, it means they could take this drug, and they could die from it, which has happened. But there are all kinds of sepsis and rupturing and hemorrhaging and everything going on with this drug.’

‘So there are two angles to this. We’re very pro-life over here. We want to go to zero abortions in the country. But the other angle is that this is a women’s health issue. So we need to decrease the number of abortions, and we need to basically save women from being harmed by this,’ he added.

Truax also noted that states with higher populations are receiving the most abortion pills through the mail and that Democrat-led states have enacted shield laws preventing GOP-led states from taking legal action against providers.

‘For instance, Texas, they don’t have abortion anymore, but they sure do,’ he said. ‘People think it’s down to zero. It’s not at all. It’s about where it was. So you have all these abortionists in, to name a few, Massachusetts and California. There’s dispensing organizations now around the country and around the globe that will mail these things out. They’re very active getting these abortion drugs into states that said, ‘we don’t want abortion here.”

The FDA continues to keep the in-person dispensing requirement for mifepristone suspended — a safety rule that had been in place for roughly 20 years before Biden’s FDA permanently removed it following a COVID-era suspension.

The policy was met with legal challenges under the previous administration, but the Supreme Court allowed it to remain in effect after ruling that the plaintiffs lacked standing. The Fifth Circuit Court of Appeals had ruled the FDA’s action under Biden was likely ‘arbitrary and capricious’ under the Administrative Procedure Act.

Truax said that the Trump administration has the authority to nix the policy, and urged the federal government to do so.

‘I think that from a political standpoint, they’d rather not talk about it. But our point is, from a political standpoint, it’s going to start hurting. Pro-life Americans are really grateful to the president for the Supreme Court that we have, they got Roe thrown out, as it should have been a long time ago. But there’s more work to be done. We’re grateful for defunding Planned Parenthood. That’s great for a year. But the bottom line is, if the number of abortions is actually going up and there’s a step you could take to stop it, we got to do that,’ he said.

‘There’s a massive number of pro-life Americans that are base supporters of the president who may say, ‘wait a minute, we’ve been in power for this entire time and the number of abortions keeps going up, and we could have stopped it,” he added.

Republican lawmakers on Capitol Hill and state officials have been calling on the Trump administration to take action.

Last summer, more than 20 attorneys general urged Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary to complete a safety review of mifepristone and consider reinstating safeguards or removing the drug from the market. Kennedy and Makary vowed to conduct a new review of the safety of the drug, but they have not released a timeline for the results.

‘President Trump, Secretary Kennedy, and Commissioner Makary already have the tools at their disposal to reverse the legally and scientifically dubious decisions of the Biden Administration’s FDA and to reinstate the in-person dispensing requirement. The Trump Administration must act swiftly to restore commonsense medical safeguards to the chemical abortion pill,’ the ROAF report says.

This post appeared first on FOX NEWS

Keep Reading

Business

Trump administration alleges Nike discriminated against white workers

February 5, 2026 Business 3 Mins Read

The U.S. Equal Employment Opportunity Commission said Wednesday that it is investigating Nike for allegedly discriminating against white workers.

The agency that polices discrimination in the workplace filed an action in federal court in Missouri to compel the publicly traded athletic shoe and apparel giant to produce information in response to a subpoena the agency served on the company last fall, according to court filings reviewed by NBC News.

The EEOC said it was investigating allegations that the company’s mentorship and training programs and its personnel decisions gave nonwhite employees preferential treatment that amounts, according to the agency, to discrimination against white workers.

Nike is the world’s largest sportswear and apparel company, with nearly 80,000 employees and revenues of around $51.4 billion in 2024.

The allegations were not made by workers at Nike who believed they had been the targets of unfair treatment, however, as is typically the case in EEOC investigations.

Instead, the court filings show that this case stems from a commissioner’s charge brought by then-commissioner Andrea Lucas herself in May 2024, and based on publicly available information such as Nike’s own annual “Impact Reports” and information on its public website.

The EEOC’s request that a judge enforce the subpoena is the latest instance of the Trump administration using a federal agency that is typically charged with preventing and responding to discrimination against nonwhite Americans, and deploying it instead to protect what it says are the underrepresented interests of white people.

Nike has objected in court to many of the EEOC’s demands to documents over the last several months, arguing that they are vague, overly broad, and seek information dating back to well before the period in question.

“This feels like a surprising and unusual escalation,” a Nike spokesperson said. “We have had extensive, good-faith participation in an EEOC inquiry into our personnel practices, programs, and decisions and have had ongoing efforts to provide information and engage constructively with the agency.”

The spokesperson added that Nike has shared “thousands of pages of information and detailed written responses” in connection with the agency’s inquiry and said the company is in the “process of providing additional information.” Nike will respond to the agency’s petition, the spokesperson said.

Lucas was appointed chair of the EEOC by President Donald Trump in November 2025 after serving as a commissioner since 2020, when the president nominated Lucas to the agency.

The agency said it filed the subpoena enforcement action after “first attempting to obtain voluntary compliance with its investigative requests.”

This post appeared first on NBC NEWS

Keep Reading